Prospects for the use of statins in antiviral therapy
Inhibitors of hydroxymethylglutaryl-CoA reductase, in addition to suppressing cholesterol synthesis, have an antiviral effect. Clinical studies have shown antiviral efficacy of statins against COVID-19, HCV, HBV, RSV, HIV, influenza viruses. The ability of statins to inhibit influenza viruses, COVID...
Main Author: | Mustafin R.N. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy
2023-03-01
|
Series: | Клиническая микробиология и антимикробная химиотерапия |
Subjects: | |
Online Access: | https://cmac-journal.ru/publication/2023/1/cmac-2023-t25-n1-p56/cmac-2023-t25-n1-p56.pdf |
Similar Items
-
Disputable questions of statins antitumor effects in hemoblastoses
by: R. N. Mustafin
Published: (2022-07-01) -
Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy
by: Madison Pereira, et al.
Published: (2022-07-01) -
The Statin Target HMG-Coenzyme a Reductase (Hmgcr) Regulates Sleep Homeostasis in <i>Drosophila</i>
by: Ahmed M. Alsehli, et al.
Published: (2022-01-01) -
Atherosclerosis and Statins
by: Marzieh Shahrezaei, et al.
Published: (2011-07-01) -
Hypolidemic therapy today. New challenges and opportunities of statines
by: V. P. Mikhin, et al.
Published: (2018-04-01)